Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Solasto Corp. ( (JP:6197) ) has shared an announcement.
Solasto Corporation reported its Q1 FY2025 financial results, showing a slight increase in net sales by 2.4% compared to the previous year, reaching 34,926 million yen. Despite a decline in operating profit by 4.1%, the company experienced a significant increase in net income by 34.5%. The company maintained its dividend forecast for FY2025, with a slight increase expected in the year-end dividend per share. The financial results indicate a stable market position, although there are challenges in maintaining operating profit levels.
The most recent analyst rating on (JP:6197) stock is a Hold with a Yen550.00 price target. To see the full list of analyst forecasts on Solasto Corp. stock, see the JP:6197 Stock Forecast page.
More about Solasto Corp.
Solasto Corporation operates in the healthcare and medical services industry, focusing on providing medical administration outsourcing services and home care services in Japan.
Average Trading Volume: 274,561
Technical Sentiment Signal: Sell
Current Market Cap: Yen42.25B
For detailed information about 6197 stock, go to TipRanks’ Stock Analysis page.